Deglusterol: Clinical Approaches in Type 2 Diabetes and potential therapeutic application in NAFLD in Middle East Patients

Deglusterol: Clinical Approaches in Type 2 Diabetes and potential therapeutic application in NAFLD in Middle East Patients

Monday, January 29, 2024 4:30 PM to 5:00 PM · 30 min. (Asia/Dubai)
Transformation Zone

Information

Clinical Approaches in Type 2 Diabetes and potential therapeutic application in Non-Alcohol Fatty Liver Disease (NAFLD) in Middle East Patients

This is an ATTEND IN PERSON session, taking place in-person at Transformation Zone (P.K.10) . If you have any questions about the session, please send an email to Customer Success Team, IMCustomerSuccess@informa.com.

Session Type
Non-CME
Conference Track
Haematology
Caregen Co., Ltd.H4.C59Caregen, a global leader in peptide research and development, is a global biotechnology company that has commercialized the unlimited expandability of its patented peptides as many innovative products since its establishment in 2001. Over 600 different functional peptides developed by Caregen for the past 23 years have opened new paradigm in the field of biotechnology by expanding its applications to cosmeceutical, Class III medical devices, food supplement, and pharmaceuticals. We are striving to dramatically improve human life and health providing total health care solution through the development, production, and supply of various peptides. Our innovative peptide-based products provide solutions to many people around the world who are pursuing health and beauty with our unique skin delivery technology that maximize the efficacy and effectiveness of products.

Log in